Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus
A Study to identify toxicity and optimal photodynamic treatment parameters using the photosensitizer 2-\[1-hydroxyethyl\]-2-devinylpyropheophorbide-a (HPPH) in high grade dysplasia, carcinoma-in-situ, or early adenocarcinoma in Barrett's esophagus.
Barrett's Esophagus|CIS|High Grade Dysplasia
DRUG: HPPH
Toxicity of HPPH at different doses, 2 days
Determine optimal PDT parameters using HPPH in HGD, CIS and Barrett's esophagus, Determine optimal PDT parameters using HPPH in HGD, CIS and Barrett's esophagus, length of study
A Study to identify toxicity and optimal photodynamic treatment parameters using the photosensitizer 2-\[1-hydroxyethyl\]-2-devinylpyropheophorbide-a (HPPH) in high grade dysplasia, carcinoma-in-situ, or early adenocarcinoma in Barrett's esophagus.